Jon Ukropec is an experienced leader in medical affairs with a focus on hematology and oncology. Currently serving as the Head of US Medical Affairs at Genmab since November 2020, Jon is responsible for executing the US Medical Affairs strategy for Epkinly and various pipeline hematology assets. Prior roles include Senior Global Medical Affairs Lead for Darzalex at Janssen Pharmaceutical Companies, where Jon contributed to myeloma franchise strategies, and key positions at Bristol Myers Squibb, where Jon led global strategies for oncology products. Jon has a robust educational background with a PhD in Molecular Physiology from the University of Pennsylvania and multiple degrees in toxicology and biochemistry.
This person is not in the org chart
This person is not in any teams
This person is not in any offices